- Home
- ALGS vs TOP Comparison
ALGS vs TOP Comparison
Compare ALGS & TOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- TOP
- Stock Information
- Founded
- ALGS 2018
- TOP 2015
- Country
- ALGS United States
- TOP Hong Kong
- Employees
- ALGS N/A
- TOP N/A
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- TOP Investment Bankers/Brokers/Service
- Sector
- ALGS Health Care
- TOP Finance
- Exchange
- ALGS Nasdaq
- TOP Nasdaq
- Market Cap
- ALGS 38.8M
- TOP 45.2M
- IPO Year
- ALGS 2020
- TOP 2022
- Fundamental
- Price
- ALGS $7.14
- TOP $1.25
- Analyst Decision
- ALGS Strong Buy
- TOP
- Analyst Count
- ALGS 1
- TOP 0
- Target Price
- ALGS $70.00
- TOP N/A
- AVG Volume (30 Days)
- ALGS 140.5K
- TOP 49.6K
- Earning Date
- ALGS 03-10-2025
- TOP 04-08-2025
- Dividend Yield
- ALGS N/A
- TOP N/A
- EPS Growth
- ALGS N/A
- TOP N/A
- EPS
- ALGS N/A
- TOP N/A
- Revenue
- ALGS $3,945,000.00
- TOP $2,730,890.00
- Revenue This Year
- ALGS $580.86
- TOP N/A
- Revenue Next Year
- ALGS N/A
- TOP N/A
- P/E Ratio
- ALGS N/A
- TOP N/A
- Revenue Growth
- ALGS N/A
- TOP N/A
- 52 Week Low
- ALGS $6.76
- TOP $1.13
- 52 Week High
- ALGS $46.80
- TOP $3.30
- Technical
- Relative Strength Index (RSI)
- ALGS 24.28
- TOP 44.83
- Support Level
- ALGS $10.45
- TOP $1.21
- Resistance Level
- ALGS $9.76
- TOP $1.35
- Average True Range (ATR)
- ALGS 1.11
- TOP 0.06
- MACD
- ALGS 0.15
- TOP 0.01
- Stochastic Oscillator
- ALGS 2.13
- TOP 47.37
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About TOP TOP Financial Group Limited
TOP Financial Group Ltd is an online brokerage firm in Hong Kong specializing in trading local and overseas equities, futures, and options products. The Company generates brokerage commission income by enabling its customers to trade on multiple exchanges present globally. The company operates in only one segment which is the futures brokerage service.